Dimer Health

Dimer Health operates within the post-acute care market, which is experiencing significant growth due to aging populations and a shift toward value-based care models that prioritize reducing hospital readmissions. The company targets the period immediately following discharge, which accounts for billions in healthcare costs annually from preventable readmissions. Dimer Health's business model involves partnering with health systems, healthcare providers, and payers to improve patient outcomes and lower costs. The company validated its clinical model first by providing services directly to patients before scaling its technology, a strategy that helped demonstrate product-market fit and generate early revenue.

The core of Dimer Health's offering is its AI-powered platform, "AiME," combined with a dedicated clinical service line. AiME engages with patients at home, analyzes symptoms in the context of their medical history, and identifies early risk signals. When the AI detects a potential issue, the case is escalated to a licensed clinician, termed a "Transitionist," who manages the patient's full care episode from discharge through recovery. This service includes personalized recovery plans, medication management, and 24/7 medical support via telehealth. The company reports that its model can reduce unnecessary readmissions by up to 67% and has achieved a 30% quarter-over-quarter revenue growth. As of early 2026, Dimer Health operates in eight states with partnerships across 28 healthcare facilities. The company has raised a total of approximately $16-20 million in funding, including a $13.5 million Series A round in 2026 led by Team8 and Table Management.